Cocrystal Pharma Inc.

NASDAQ: COCP · Real-Time Price · USD
1.70
0.02 (1.19%)
At close: Aug 15, 2025, 3:59 PM
1.72
1.11%
After-hours: Aug 15, 2025, 04:31 PM EDT

Cocrystal Pharma Balance Sheet Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year FY 2024 FY 2023 FY 2022 FY 2021
Period Ending Dec 31, 2024 Dec 31, 2023 Dec 31, 2022 Dec 31, 2021
Cash & Equivalents
9.86M 26.35M 37.14M 58.7M
Short-Term Investments
n/a n/a n/a n/a
Long-Term Investments
n/a n/a n/a n/a
Other Long-Term Assets
29K 46K 46K 46K
Receivables
1.22M 890K 716K n/a
Inventory
n/a n/a 75K n/a
Other Current Assets
505K 1.85M 2.32M 50K
Total Current Assets
11.58M 29.09M 40.18M 59.32M
Property-Plant & Equipment
1.85M 2.12M 616K 931K
Goodwill & Intangibles
n/a n/a n/a 19.09M
Total Long-Term Assets
1.88M 2.17M 662K 20.07M
Total Assets
13.46M 31.26M 40.84M 79.39M
Account Payables
1.54M 1.22M 614K 578K
Deferred Revenue
n/a n/a n/a 719K
Short-Term Debt
301K n/a 240K 236K
Other Current Liabilities
117K 1.69M -8K -120K
Total Current Liabilities
2.43M 3.26M 1.22M 1.54M
Long-Term Debt
n/a n/a n/a n/a
Other Long-Term Liabilities
n/a n/a n/a n/a
Total Long-Term Liabilities
1.5M 1.61M 57K 298K
Total Liabilities
3.93M 4.88M 1.27M 1.84M
Total Debt
1.81M 1.85M 297K 534K
Common Stock
10K 10K 8K 98K
Retained Earnings
-333.42M -315.91M -297.93M -259.09M
Comprehensive Income
n/a n/a 0.00 n/a
Shareholders Equity
9.52M 26.38M 39.57M 77.55M
Total Investments
n/a n/a n/a n/a